Sigachi Industries informs about press release

21 Jan 2026 Evaluate
Sigachi Industries has informed that Sigachi Industries, a leading Indian pharmaceutical company, today announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. A press release to this extent is enclosed.

The above information is a part of company’s filings submitted to BSE.

Sigachi Industries Share Price

19.27 0.16 (0.84%)
20-Mar-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.20
Dr. Reddys Lab 1295.00
Cipla 1260.65
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×